ArticleAnnals of translational medicine2022

TAK-242 ameliorates epileptic symptoms in mice by inhibiting the TLR4/NF-κB signaling pathway.

Jibo Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.